natgillin/translations-raw huggingface dataset:
Du skal bruge denne sprøjte, hvis den samlede mængde, du skal tage, er mindre end eller lig med 1 ml (hver graduering af 0,1 ml indeholder 2 mg mercaptopurin). 
You should use this one if the total amount you have to take is less than or equal to 1 ml (each graduation of 0.1 ml contains 2 mg of mercaptopurine).
6-mercaptopurin er som andre antimetabolitter mutagen og forårsager kromosomafvigelser in vitro og in vivo hos mus og rotter. 
6-mercaptopurine, in common with other antimetabolites, is mutagenic and causes chromosomal aberrations in vitro and in vivo in mice and rats.
Derfor kan Xaluprine tages sammen med mad eller på tom mave, men patienter bør standardisere deres administrationsmetode. 
Therefore, Xaluprine may be taken with food or on an empty stomach, but patients should standardise the method of administration.
De kræver generelt en dosisreduktion, særligt de patienter, der er homozygote for NUDT15-varianten (se pkt. 
They generally require dose reduction, particularly those being NUDT15 variant homozygotes (see 4.2).
Tag engangshandsker på, inden du håndterer Xaluprine. 
Put on disposable hand gloves before handling Xaluprine.
Allopurinol og andre xanthinoxidasehæmmere reducerer 6-mercaptopurins katabolismehastighed. 
Allopurinol and other xanthine oxidase inhibitors decrease the rate of catabolism of 6-mercaptopurine.
Følg nedenstående instruktioner, når du tager medicinen: 
When you use the medicine follow the instructions below:
Patienten skal instrueres i omgående at ophøre med at tage Xaluprine, hvis der er tegn på gulsot (se pkt. 
The patient should be instructed to discontinue Xaluprine immediately if jaundice becomes apparent (see section 4.8).
LÆGEMIDDELFORM OG INDHOLD (PAKNINGSSTØRRELSE) Oral suspension. 
PHARMACEUTICAL FORM AND CONTENTS Oral suspension.
Patienter i immunsupprimerende behandling, herunder med mercaptopurin, har en øget risiko for at udvikle lymfoproliferative sygdomme og andre maligniteter, især hudcancer (melanom og non-melanom), sarkomer (Kaposi og non-Kaposi) og cervixcancer in situ. 
Patients receiving immunosuppressive therapy, including mercaptopurine, are at an increased risk of developing lymphoproliferative disorders and other malignancies, notably skin cancers (melanoma and non-melanoma), sarcomas (Kaposi's and non-Kaposi's) and uterine cervical cancer in situ.
Hvis du holder op med at tage Xaluprine 
If you stop taking Xaluprine
6-merpactopurins intracellulære anabolisme katalyseres af flere enzymer til dannelse af 6-thioguanin-nukleotider (TGN'er), men der dannes flere forskellige midlertidige TGN'er i processen mod TGN'er. 
The intracellular anabolism of 6-merpactopurine is catalysed by several enzymes to eventually form 6-thioguanine nucleotides (TGNs), but a variety of intermediary TGNs are formed en route to the TGNs.
Der er indberettet tilfælde af neutropenisk sepsis hos patienter med ALL, der fik 6-mercaptopurin. 
Cases of neutropenic sepsis have been reported in patients receiving 6-mercaptopurine for ALL.
TPMT katalyserer imidlertid også S-methyleringen af den primære nukleotide metabolit, TIMP, og danner methylthioinosin-monofosfat (mTIMP). 
TPMT also catalyses the S-methylation of the principle nucleotide metabolite, TIMP, to form methylthioinosine monophosphate (mTIMP).
Opbevaring - Opbevar lægemidlet utilgængeligt for børn, helst i et låst skab. 
- Keep this medicine out of the sight and reach of children, preferably in a locked cupboard.
Xaluprine indeholder mercaptopurin. 
Xaluprine contains mercaptopurine.
Behandling med 6-mercaptopurin forårsager knoglemarvssuppression, som fører til leukopeni og trombocytopeni og mindre hyppigt til anæmi. 
Treatment with 6-mercaptopurine causes bone marrow suppression leading to leucopenia and thrombocytopenia and, less frequently, to anaemia.
Patienter skal monitoreres nøje for dosisrelaterede bivirkninger (se pkt. 
Patients should be closely monitored for dose related adverse reactions (see section 4.4).
Kontrollér, at hætten er lukket tæt. 
Ensure that the cap is tightly closed.
Kontraception til mænd og kvinder. 
Contraception in males and females
Samtidig administration af vaccine mod gul feber er kontraindiceret på grund af risikoen for dødelig sygdom hos immunkompromitterede patienter (se pkt. 
Effects of mercaptopurine on other medicinal products Concomitant administration of yellow fever vaccine is contraindicated, due to the risk of fatal disease in immunocompromised patients (see section 4.3)
Flere medfødte abnormiteter har været rapporteret efter behandling af moderen med 6-mercaptopurin i kombination med andre kemoterapimidler. 
Multiple congenital abnormalities have been reported following maternal 6-mercatopurine treatment in combination with other chemotherapy agents.
Makrofag-aktiveringssyndrom 
Macrophage activation syndrome
Da farmakokinetikken for 6-mercaptopurin ikke er formelt undersøgt ved nyreinsufficiens, kan der ikke gives nogen specifikke dosisanbefalinger. 
Since 6-mercaptopurine pharmacokinetics has not been formally studied in renal impairment, no specific dose recommendations can be given.
Andre bivirkninger (ikke kendt hyppighed) - en sjælden type kræft (hepatosplenisk T-celle lymfom (se punkt 2, Advarsler og forsigtighedsregler) - Overfølsomhed over for sollys, der giver hudreaktioner 
Other side effects (the frequency is unknown) - a rare type of cancer (hepatosplenic T-cell lymphoma), (see section 2, Warnings and
1 ml suspension indeholder 3 mg aspartam, 1 mg methylhydroxybenzoat (som natriumsalt), 0,5 mg ethylhydroxybenzoat (som natriumsalt) og sakkarose (spor). 
One ml of suspension contains 3 mg aspartame, 1 mg methyl hydroxybenzoate (as the sodium salt), 0.5 mg ethyl hydroxybenzoate (as the sodium salt) and sucrose (trace).
Lægemidlet indeholder også natriummethylparahydroxybenzoat og natriumethylparahydroxybenzoater, som kan give allergiske reaktioner (muligvis forsinkede). 
It also contains sodium methyl parahydroxybenzoate and sodium ethyl parahydroxybenzoate which may cause allergic reaction (possibly delayed).
Patienter med et nedarvet, muteret NUDT15-gen har en øget risiko for alvorlig 6mercaptopurintoksicitet (se pkt. 
Patients with inherited mutated NUDT15 gene are at increased risk for severe 6-mercaptopurine toxicity, (see 4.4).
Da farmakokinetikken for 6-mercaptopurin ikke er formelt undersøgt ved leverinsufficiens, kan der ikke gives nogen specifikke dosisanbefalinger. 
Since 6-mercaptopurine pharmacokinetics has not been formally studied in hepatic impairment, no specific dose recommendations can be given.
De vigtigste bivirkninger ved behandling med 6-mercaptopurin er knoglemarvssuppression, som fører til leukopeni og trombocytopeni. 
The main adverse reaction of treatment with 6-mercaptopurine is bone marrow suppression leading to leucopenia and thrombocytopenia.
FREMSTILLERENS BATCHNUMMER Parti: 
BATCH NUMBER Lot:
Din læge eller apotekspersonalet vil fortælle dig, hvilken sprøjte du skal bruge, afhængigt af den ordinerede dosis. 
Your doctor or pharmacist will advise which syringe to use depending on the dose that has been prescribed.
Når allopurinol og Xaluprine administreres samtidig, er det essentielt, at der kun gives en fjerdedel af den sædvanlige dosis Xaluprine, da allopurinol reducerer 6-mercaptopurins metaboliseringshastighed via xanthinoxidase. 
Effects of other medicinal products on mercaptopurine When allopurinol and Xaluprine are administered concomitantly it is essential that only a quarter of the usual dose of Xaluprine is given since allopurinol decreases the rate of metabolism of 6-mercaptopurine via xanthine oxidase.
Xaluprine er en lyserød til brun oral suspension. 
What Xaluprine looks like and contents of the pack Xaluprine is a pink to brown oral suspension.
Du må ikke amme, mens du tager Xaluprine. 
Do not breast-feed while taking Xaluprine.
Det skal du vide, før du begynder at tage Xaluprine 
What you need to know before you take Xaluprine
Der er rapporteret om hæmning af warfarins antikoagulerende virkning, når midlet gives samtidig med 6-mercaptopurin. 
Inhibition of the anticoagulant effect of warfarin, when given with 6-mercaptopurine, has been reported.
Galdestase, hepatotoksicitet 
Biliary stasis, hepatotoxicity
KVALITATIV OG KVANTITATIV SAMMENSÆTNING 1 ml suspension indeholder 20 mg mercaptopurin (som monohydrat). 
QUALITATIVE AND QUANTITATIVE COMPOSITION One ml of suspension contains 20 mg mercaptopurine (as monohydrate).
1 ml suspension indeholder 20 mg mercaptopurin-monohydrat. 
One ml of suspension contains 20 mg of mercaptopurine monohydrate.
Din læge eller apotekspersonalet fortæller dig, hvilken sprøjte du skal bruge afhængig af den ordinerede dosis. 
Your doctor or pharmacist will advise which syringe to use depending on the dose that has been prescribed
Xaluprine indeholder saccharose. 
Xaluprine contains sucrose.
Knoglemarvssuppression, leukopeni og trombocytopeni 
Bone marrow suppression; leucopenia and thrombocytopenia
Xaluprine indeholder: 
What Xaluprine contains
Xaluprine indeholder også natriummethylparahydroxybenzoat (E219) og natriumethylparahydroxy-benzoat (E215), som kan give allergiske reaktioner (muligvis forsinkede). 
Xaluprine also contains sodium methyl parahydroxybenzoate (E219) and sodium ethyl parahydroxybenzoate (E215) which may cause allergic reactions (possibly delayed).
6-mercaptopurin-metabolitter hæmmer den indbyrdes konvertering af de novo-purinsyntese og purinnukleotider. 
The 6-mercaptopurine metabolites inhibit de novo purine synthesis and purine nucleotide interconversions.
Ikke almindelige (rammer mindre end 1 ud af 100) - mundsår - betændelse i bugspytkirtlen - ledsmerter - hududslæt - feber - permanent leverskade (levernekrose) 
Uncommon (affects less than 1 in 100 people) - mouth ulcers - inflamed pancreas - joint pain - skin rash - fever - permanent damage to the liver (hepatic necrosis)
Brug af Xaluprine sammen med mad og drikke Xaluprine kan tages sammen med mad eller på tom mave. 
Xaluprine may be taken with food or on an empty stomach.
Der er indberettet tilfælde af symptomatisk hypoglykæmi hos børn med ALL, som fik 6-mercaptopurin (se pkt. 
Cases of symptomatic hypoglycaemia have been reported in children with ALL receiving 6-mercaptopurine (see section 4.8).
Behandling med Xaluprine kan medføre øget risiko for: - udvikling af en alvorlig lidelse, der hedder makrofag-aktiveringssyndrom (kraftig aktivering af hvide blodlegemer forbundet med en betændelseslignende reaktion (inflammation)). 
Taking Xaluprine could put you at greater risk of: - developing a serious condition called Macrophage Activation Syndrome (excessive activation of white blood cells associated with inflammation), which usually occurs in people who have certain types of arthritis
Skyl øjeblikkeligt og grundigt med sæbe og vand (se pkt. 
If the suspension comes into contact with skin or mucosa, it should be washed immediately and thoroughly with soap and water (see section 6.6).
Hver pakning af Xaluprine indeholder en flaske med medicin, en hætte, en flaskeadapter og to doseringssprøjter (en violet 1 ml sprøjte og en hvid 5 ml sprøjte). 
Your pack of Xaluprine contains a bottle of medicine, a cap, a bottle adaptor and two dosing syringes (a purple 1 ml syringe and a white 5 ml syringe).
INDEHAVER AF MARKEDSFØRINGSTILLADELSEN Nova Laboratories Ireland Limited 3rd Floor, Ulysses House 
MARKETING AUTHORISATION HOLDER Nova Laboratories Ireland Limited 3rd Floor, Ulysses House Foley Street, Dublin 1
Vend flasken, så den vender rigtigt, og træk forsigtigt sprøjten ud af adapteren. 
Turn the bottle back the right way up and carefully remove the syringe from the adaptor, holding it by the barrel rather than the plunger.
DATO FOR FØRSTE MARKEDSFØRINGSTILLADELSE/FORNYELSE AF TILLADELSEN 
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 09 March 2012
legemsoverfladeareal (BSA) dagligt, men bør være lavere hos patienter med reduceret eller ingen thiopurinmethyltransferase (TPMT)-enzymaktivitet (se pkt. 
Depending on phase of treatment, starting or target doses generally vary between 25-75 mg/m2 body surface area (BSA) per day, but should be lower in patients with reduced or absent Thiopurine Methyl Transferase (TPMT) enzyme activity (see section 4.4).
Udløbsdatoen er den sidste dag i den nævnte måned. 
The expiry date refers to the last day of that month, - Do not store above 25°C.
Når du tager Xaluprine, skal du derfor undgå for megen eksponering for sollys, og du skal bruge beskyttende påklædning og solcreme med høj beskyttelsesfaktor. 
Therefore, when taking Xaluprine, avoid excessive exposure to sunlight, wear protective clothing and use protective sunscreen with a high protection factor - lymphoproliferative disorders o treatment with Xaluprine increases your risk of getting a type of cancer called lymphoproliferative disorder.
Hver pakning indeholder en flaske, en flaskeadapter og to doseringssprøjter (en violet sprøjte gradueret til 1 ml og en hvid sprøjte gradueret til 5 ml). 
Each pack contains one bottle, a bottle adaptor and two dosing syringes (a purple syringe graduated to 1 ml and a white syringe graduated to 5 ml).
Hver pakning indeholder en flaske, en HDPE-flaskeadapter og 2 polyethylen-doseringssprøjter (en violet sprøjte gradueret til 1 ml og en hvid sprøjte gradueret til 5 ml). 
Each pack contains one bottle, an HDPE bottle adaptor and 2 polyethylene dosing syringes (a purple syringe graduated to 1 ml and a white syringe graduated to 5 ml).
ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER 1 ml suspension indeholder 20 mg mercaptopurin (som monohydrat). 
STATEMENT OF ACTIVE SUBSTANCE(S) One ml of suspension contains 20 mg mercaptopurine (as monohydrate).
Arthralgi, udslæt, lægemiddelinduceret feber 
Arthralgia, skin rash, drug fever
Da der foreligger dokumentation in vitro for, at aminosalicylatderivater (f.eks. olsalazin, mesalazin eller sulfazalazin) hæmmer TPMT-enzymet, som metaboliserer 6-mercaptopurin, skal disse administreres med forsigtighed til patienter, som får samtidig behandling med Xaluprine (se pkt. 
olsalazine, mesalazine or sulfazalazine) inhibit the TPMT enzyme, which metabolises 6-mercaptopurine, they should be administered with caution to patients receiving concurrent Xaluprine therapy (see section 4.4).
Derfor skal behandlingen omgående afbrydes ved det første tegn på et unormalt stort fald i tallene. 
The leucocyte and platelet counts continue to fall after treatment is stopped, so at the first sign of an abnormally large fall in the counts, treatment should be interrupted immediately.
Øvrige indholdsstoffer: xanthangumi, aspartam (E951), koncentreret hindbærsaft, sakkarose, natriummethylparahydroxybenzoat (E219), natriumethylparahydroxybenzoat (E215), kaliumsorbat (E202), natriumhydroxid og renset vand (se punkt 2 vedrørende flere oplysninger om aspartam, natriummethylparahydroxybenzoat (E219) og natriumethylparahydroxybenzoat (E215) og saccharose). 
The other ingredients are xanthan gum, aspartame (E951), concentrated raspberry juice, sucrose, sodium methyl parahydroxybenzoate (E219), sodium ethyl parahydroxybenzoate (E215), potassium sorbate (E202), sodium hydroxide and purified water (see section 2 Xaluprine contains aspartame, sodium methyl parahydroxybenzoate (E219), sodium ethyl parahydroxybenzoate (E215) and sucrose).
LÆGEMIDLETS NAVN Xaluprine 20 mg/ml oral suspension 
NAME OF THE MEDICINAL PRODUCT Xaluprine 20 mg/ml oral suspension
Symptomer kan være: - hududslæt - feber - ledsmerter - hævelser i ansigtet 
- Allergic reaction, the signs may include: o skin rashes o high temperature o joint pain o swollen face
6-mercaptopurin er påvist i råmælk og modermælk hos kvinder i behandling med azathioprin. 
6-mercaptopurine has been identified in the colostrum and breast-milk of women receiving azathioprine treatment and thus women receiving Xaluprine should not breast-feed.
Sådan skal du tage Xaluprine 
How to take Xaluprine
Kontakt lægen, apotekspersonalet eller sundhedspersonalet, før du tager Xaluprine, hvis du: - er blevet vaccineret mod gul feber. 
Talk to your doctor, pharmacist or nurse before taking Xaluprine if: - you have been vaccinated with yellow fever vaccine - you have kidney or liver problems, as your doctor will need to check that they are working properly.
Xaluprine indeholder aspartam, natriummethylparahydroxybenzoat (E219), natriumethylparahydroxybenzoat (E215) og saccharose. 
Xaluprine contains aspartame, sodium methyl parahydroxybenzoate (E219), sodium ethyl parahydroxybenzoate (E215) and sucrose
LÆGEMIDLETS NAVN Xaluprine 20 mg/ml oral suspension mercaptopurin 
NAME OF THE MEDICINAL PRODUCT Xaluprine 20 mg/ml oral suspension mercaptopurine
Hepatisk nekrose 
Hepatic necrosis
Hvis du får immunsupprimerende behandling, kan behandling med Xaluprine medføre en øget risiko for: - tumorer, herunder hudkræft. 
If you are receiving immunosuppressive therapy, taking Xaluprine could put you at greater risk of:
6-mercaptopurin udskilles primært via metabolisme. 
The main route of elimination for 6-mercaptopurine is by metabolism.
Spildt medicin skal straks tørres op. For at reducere risikoen for eksponering bør du bruge engangshandsker ved håndtering af Xaluprine. 
To decrease the risk of exposure disposable gloves should be used when handling Xaluprine.
- sulfasalazin (anvendes til reumatoid artritis eller ulcerativ colitis) - anti-epileptiske lægemidler som fenytoin, carbamazepin. 
- anti-epileptic medicines such as phenytoin, carbamazepine.
Undgå, at Xaluprine kommer i kontakt med hud eller slimhinder. 
Xaluprine contact with skin or mucous membrane must be avoided.
Natriummethylparahydroxybenzoat (E219) Natriumethylparahydroxybenzoat (E215) Kaliumsorbat (E202) 
Sodium methyl parahydroxybenzoate (E219) Sodium ethyl parahydroxybenzoate (E215) Potassium sorbate (E202) Sodium hydroxide
Indeholder også: natriummethylparahydroxybenzoat (E219), natriumethylparahydroxybenzoat (E215), kaliumsorbat (E202), natriumhydroxid, aspartam (E951) og sakkarose. 
Also contains: sodium methyl parahydroxybenzoate (E219), sodium ethyl parahydroxybenzoate (E215), potassium sorbate (E202), sodium hydroxide, aspartame (E951) and sucrose.
- Må ikke opbevares ved temperaturer over 25° C. - Hold flasken tæt tillukket for at forhindre, at produktet bliver ødelagt og for at minimere risikoen for at komme til at spilde det. - Ubrugt indhold skal kasseres 56 dage efter åbning af flasken. 
- After first opening of the bottle, discard any unused contents after 56 days.
Pankreatitis, mundsår 
Pancreatitis, oral ulceration
Vaccinationer, mens du tager Xaluprine 
Other medicines and Xaluprine
Skyl øjeblikkeligt og grundigt med sæbe og vand, hvis Xaluprine kommer i kontakt med hud, øjne eller næse. 
If Xaluprine comes into contact with skin, eyes or nose, it should be washed immediately and thoroughly with soap and water.
Din læge kan af og til ændre din dosis af Xaluprine, for eksempel på grund af forskellige test. Spørg altid lægen eller sundhedspersonalet, hvis du er i tvivl om, hvor meget medicin du skal tage. 
Sometimes the doctor may change your dose of Xaluprine for example as a result of different tests.
Må ikke opbevares ved temperaturer over 25 C. Hold flasken tæt tillukket (se pkt. 
Do not store above 25ºC.
Hvis du har taget for meget Xaluprine 
If you forget to take Xaluprine
Anvendes inden: 
NN:
Det skal du vide, før du begynder at tage Xaluprine Sådan skal du tage Xaluprine Bivirkninger 
What Xaluprine is and what it is used for What you need to know before you take Xaluprine How to take Xaluprine
Kontakt lægen eller apotekspersonalet, hvis en bivirkning er generende eller bliver værre, eller du får bivirkninger, som ikke er nævnt her. 
Tell your doctor or pharmacist if you are taking or, have recently taken or might take any other medicines, including medicines obtained without a prescription.
Spørg lægen eller apotekspersonalet, hvis der er noget, du er i tvivl om vedrørende brugen af denne medicin. 
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Skyl øjeblikkeligt og grundigt med sæbe og vand, hvis Xaluprine kommer i kontakt med hud eller slimhinder. 
If Xaluprine comes into contact with skin or mucosa, it should be washed immediately and thoroughly with soap and water.
Ansigtsødem 
Posology
Det tilrådes imidlertid at monitorere nyre- og leverfunktion hos disse patienter. 
However, it is advisable to monitor renal and hepatic function in these patients, and if there is any impairment, consideration should be given to reducing the Xaluprine dose.
Søg omgående speciallæge, eller tag på hospitalet, hvis du får nogen af de følgende bivirkninger: Allergisk reaktion. 
If you get any of the following side effects, talk to your specialist doctor or go to hospital immediately:
Dette gælder også medicin, som ikke er købt på recept, og naturlægemidler. 
This includes herbal medicines.
32 mg Dispergibel tablet 
32 mg Dispersible Tablet blister (alu/alu)
MARKEDSFØRINGSTILLADELSESNUMMER (NUMRE) EU/1/09/548/001 - 007 
MARKETING AUTHORISATION NUMBER(S) EU/1/09/548/001 - 007
Spørg Deres læge eller apoteket til råds,inden De tager nogen form for medicin. 
Ask your doctor or pharmacist for advice before taking any medicine.
Når personer med poor metabolisme modtog 600 mg/150 mg regimet, var eksponeringen for den aktive metabolit større end for 300 mg/75 regimet. 
When poor metabolisers received the 600 mg/150 mg regimen, active metabolite exposure was greater than with the 300 mg/75 mg regimen.
Der der dog foretaget et antal retrospektive analyser for at evaluere denne effekt hos patienter i behandling med clopidogrel, for hvem der foreligger resultater af genotyping: CURE (n=2721), CHARISMA (n=2428), CLARITYTIMI 28 (n=227), TRITON-TIMI 38 (n=1477) og ACTIVE-A (n=601) såvel som et antal publicerede kohortestudier. 
There have been a number of retrospective analyses, however, to evaluate this effect in patients treated with clopidogrel for whom there are genotyping results: CURE (n=2721), CHARISMA (n=2428), CLARITY-TIMI 28 (n=227), TRITON-TIMI 38 (n=1477), and ACTIVE-A (n=601), as well as a number of published cohort studies.
Hvis De har glemt at tage Clopidogrel Acino Pharma GmbH Hvis De glemmer at tage en dosis Clopidogrel Acino Pharma GmbH til sædvanlig tid, men kommer i tanke om det i løbet af 12 timer, skal De omgående tage tabletten og dernæst tage den næste tablet til sædvanlig tid. 
If you forget to take Clopidogrel Acino Pharma GmbH If you forget to take a dose of Clopidogrel Acino Pharma GmbH, but remember within 12 hours of your usual time, take your tablet straight away and then take your next tablet at the usual time.
Hos personer med poor metabolisme (poor metabolisers) var eksponeringen nedsat med 63-71 %, sammenlignet med personer med extensive metabolisme. 
In poor metabolisers, active metabolite exposure was decreased by 63-71% compared to extensive metabolisers.
SÆRLIGE OPBEVARINGSBETINGELSER Opbevares i den originale blisterpakning for at beskytte mod fugt. 
SPECIAL STORAGE CONDITIONS Store in the original blister in order to protect from moisture.
Hjælpestoffer: Hver filmovertrukket tablet indeholder 3,80 mg hydrogeneret ricinusolie. 
Excipients: each film-coated tablet contains 3.80 mg of hydrogenated castor oil.
Desuden var IPA på 32 % (24 timer) og 61 % (dag 5), hvilket var større end hos personer med poor metabolisme der modtog 300 mg/75 mg-regimet, og var omtrent ens med de andre grupper af CYP2C19-metabolisers der modtog 300 mg/75 mg regimet. 
In addition, IPA was 32% (24 hours) and 61% (Day 5), which were greater than in the poor metabolisers receiving the 300 mg/75 mg regimen, and were similar to the other CYP2C19 metaboliser groups receiving the 300 mg/75 mg regimen.
Brug af Clopidogrel Acino Pharma GmbH sammen med mad og drikke Clopidogrel Acino Pharma GmbH kan tages med eller uden mad. 
Taking Clopidogrel Acino Pharma GmbH with food and drink Clopidogrel Acino Pharma GmbH may be taken with or without food.